Mohammed Kaleem

About

Working on different types of cancer, especially breast cancer and prostate cancer, epigenetics, myocardial infarction, and obesity.
Good subjective knowledge and ability to handle projects independently and in a group
Proficient in RT-PCR, UV spectrophotometer, Microtomy, ELISA, Cell culture, MTT/WST-1, Cell proliferation assay, Flow-cytometry, Western blotting, Gel electrophoresis, etc.
Experienced in animal management for Pharmacological studies

Employment

• Savitribai Phule Pune University Associate Professor
  2025 - Present
• Dadasaheb Balpande College of Pharmacy Associate Professor
  2022 - 2025
• Humera Khan College of Pharmacy Assistant Professor
  2022 - 2022

Education

• Jeddah University PhD
  2018 - 2021
• Jamia Hamdard Faculty of Pharmacy Master
  2013 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (37)

• Genetic and epigenetic landscape of type 2 diabetes mellitus
  2026 DOI: 10.1016/B978-0-443-33590-7.00012-5
  +Save
• Elucidating the Complex Etiology of Schizophrenia: Comprehensive Insights into the Therapeutic Roles of Natural Compounds and Pharmacological Interventions
  Current Pharmaceutical Design 2026 DOI: 10.2174/0113816128362637250621113743
  +Save
• Revolutionizing Diabetic Foot Ulcer Management: Exploring the Therapeutic Potential of Natural Products
  Current Pharmaceutical Design 2025 DOI: 10.2174/0113816128398467250922104224
  +Save
• Design of Experiments Assisted Formulation Optimization and Evaluation of Efavirenz Solid Dispersion Adsorbate for Improvement in Dissolution and Flow Properties
  Drug Design, Development and Therapy 2025 DOI: 10.2147/DDDT.S517021
  +Save
• Depression unveiled: Insights into etiology and animal models for behavioral assessment, exploring the multifactorial nature and treatment of depression
  Brain Research 2025 DOI: 10.1016/j.brainres.2024.149313
  +Save
• Development of Solid Self-Nanoemulsifying Drug Delivery System of Rhein to Improve Biopharmaceutical Performance: Physiochemical Characterization, and Pharmacokinetic Evaluation
  International Journal of Nanomedicine 2025 DOI: 10.2147/IJN.S499024
  +Save
• Escitalopram oxalate-loaded chitosan nanoparticle in situ gel formulation intended for direct nose-to-brain delivery: in vitro, ex vivo, and in vivo pharmacokinetic evaluation
  Frontiers in Pharmacology 2025 DOI: 10.3389/FPHAR.2025.1577331
  +Save
• Therapeutic potential of a rhein-loaded self-nano-emulsifying drug delivery system in ameliorating LPS-induced depression: mechanistic insights and behavioral outcomes
  Frontiers in Pharmacology 2025 DOI: 10.3389/FPHAR.2025.1577080
  +Save
• Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box–Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and In Vivo Assessment
  ACS Omega 2024 DOI: 10.1021/acsomega.3c10506
  +Save
• Management of triple-negative breast cancer by natural compounds through different mechanistic pathways
  Frontiers in Genetics 2024 DOI: 10.3389/FGENE.2024.1440430
  +Save